Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB001-A in Cystic Fibrosis
NCT01695343Phase 2Completed
- Sponsor
- Humanigen
- Start
- Dec 2012
- Primary completion
- Nov 2014
- Modality
- Antibody Fragments
- Countries
- 4
01
Overview
A Phase 2 trial of KB-001 in cystic fibrosis (CF), Pseudomonas aeruginosa infection, sponsored by Humanigen. Started Dec 2012; status: completed.
02
Drugs
KB-001
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT01695343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01695343.